# Stage IV Colorectal CA ALIMTA

> **NCT00166465** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 200 (—)

## Conditions studied

- Locally Advanced Unresectable or Stage IV Colorectal Cancer

## Interventions

- **DRUG:** ALIMTA plus Oxaliplatin versus Oxaliplatin plus 5-Fluorouracil and Leucovorin (FOLFOX 4 Regimen)

## Key facts

- **NCT ID:** NCT00166465
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 200 (—)
- **Last updated:** 2011-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00166465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00166465, "Stage IV Colorectal CA ALIMTA". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00166465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*